Malignant Melanoma in an HIV-Infected Man: A Case Report and Literature Review

References

• Rabkin C S, Biggar R J, Horm J W. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer 1991; 47: 692–696
   PubMed Web of Science ®Google Scholar
• Rabkin C S, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type I. J Natl Cancer Inst 1994; 86: 1711–2716
   PubMed Web of Science ®Google Scholar
• Biggar R J, Curtis R E, Cote T R, et al. Risk of other cancers following Kaposi's sarcoma: Relation to acquired immunodeficiency syndrome. Am J Epidemiol 1994; 139: 362–468
   PubMed Web of Science ®Google Scholar
• Maiman M, Fruchter R G, Guy L, et al. Human immunodeficiency virus infection and invasive cervical cancer. Cancer 1993; 71: 402–406
   PubMed Web of Science ®Google Scholar
• Zagonel D., Errante V, Vaccher E, et al. Hodgkin's disease in patients with HIV infection and in the general population: Comparison of clinicopathological features and survival. Ann Oncol 1994; 5(Suppl 2)S37–S40
   PubMedGoogle Scholar
• Kaplan L D. Human immunodeficiency virus-associated neoplasia: changing spectrum?. J Clin Oncol 1995; 13: 2684–2687
   PubMed Web of Science ®Google Scholar
• Levine A M, Sullivan-Halley J, Pike M C, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer 1991; 68: 2466–2472
   PubMed Web of Science ®Google Scholar
• Lobo D V, Chu P, Grekin R C, Berger T G. Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Arch Dermatol 1992; 28: 623–637
   Google Scholar
• Smith K J, Skelton H G, Yeager J, et al. Cutaneous neoplasms in a military population of HIV-1 positive patients. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol 1993; 29: 400–406
   PubMed Web of Science ®Google Scholar
• Hruza G J, Snow S N. Basal cell carcinoma in a patient with acquired immune deficiency syndrome: treatment with Mohs micrographic surgery fixed tissue technique. J Dermatol Surg Oncol 1989; 15: 545–551
   PubMedGoogle Scholar
• Livrozet J M, Marchand C, Saint-Marc T, et al. Two cases of basal cell epithelioma in HIV-infected patients, with recurrence in one of them. Int Conf AIDS 1989; 5: 252, (abstract)
   Google Scholar
• Gross G, Berg B, Mausch H E. Perianal pigmented bowenoid maculosis and anal intraepithelial neoplasia in an HIV-positive homosexual man: first description of a peculiar skin lesion. Int Conf AIDS 1993; 9: 451, (abstract)
   Google Scholar
• Duvic M, Lowe L, Rapini R P, et al. Eruptive dysplastic nevi associated with human immunodeficiency virus infection. Arch Dermatol 1989; 125: 397–401
   PubMed Web of Science ®Google Scholar
• Wang C Y, Brodland D G, Su W P. Skin cancers associated with acquired immunodeficiency syndrome. Mayo Clin Proc 1995; 70: 766–772
   PubMed Web of Science ®Google Scholar
• Rasokat M, Steigleder G K, Bendik C, et al. Maligres melanom und HIV-infection. 2. Zeitschr Hautkr 1989; 64: 581–587
   PubMedGoogle Scholar
• Surawicz C M, Kirby P, Critchlow C, et al. Anal dysplasia in homosexual men: role of anoscopy and biopsy. Gastroenterology 1993; 105: 658–666
   PubMed Web of Science ®Google Scholar
• Kershmann R L, Berger T G, Weiss L M, et al. Cutaneous presentation of lymphoma in human immunodeficiency virus disease. Predominance of T cell lineage. Arch Dermatol 1995; 131: 1281–1288
   PubMed Web of Science ®Google Scholar
• Kornstein M J, Stewart R, Elder D E. Natural killer cells in the host response to melanoma. Cancer Res 1987; 47: 1411–1412
   Google Scholar
• Green M H, Young T I, Clark W H, Jr. Malignant melanoma in renal-transplant recipients. Lancet 1981; 1: 1196–1199
   PubMed Web of Science ®Google Scholar
• Muller C, Pehamberger H, Binder M, Zielinski C C. Defective interferon-augmented natural kills cell activity in patients with metastatic malignant melanoma. J Cancer Res Clin Oncol 1989; 115: 393–396
   PubMed Web of Science ®Google Scholar
• Mackensen A., Carcelain G, Viel S, et al. Direct evidence to support the immunosurveillance concept of human regressive melanoma. J Clin Invest 1994; 93: 1397–1402
   PubMed Web of Science ®Google Scholar
• Rodeck U, Herlyn M. Growth factors in melanoma. Cancer Metastasis Rev 1991; 10: 89–101
   PubMed Web of Science ®Google Scholar
• Riou J P, Ariyan S, Brandow K R, Fielding L P. The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 1995; 130: 1056–1061
   PubMed Web of Science ®Google Scholar
• Werkmeister J, McCarthy W., Hersey P. Suppressor cell activity in melanoma patients. I. Relation to tumor growth and immunoglobulin levels in vivo. Int J Cancer 1981; 28: 1–9
   PubMed Web of Science ®Google Scholar
• Pandolfi F, Boyle L., Trentin L, et al. Expression of HLA-A2 antigens in human melanoma ceil lines and its role in T-cell recognition. Cancer Res 1991; 51: 1124–1128
   PubMedGoogle Scholar
• Hersey P, Edwards A, Milton G, et al. No evidence for an association between natural killer cell activity in patients with metastatic malignant melanoma. J Cancer Res Clin Oncol 1989; 115: 393–396
   PubMed Web of Science ®Google Scholar
• Hersey P, Edwards A, McCarthy W H. Tumor-related changes in natural killer cell activity in melanoma patients. Influence of stage of disaese, tumor thickness and age of patient. Int J Cancer 1980; 25: 187–194
   PubMed Web of Science ®Google Scholar
• McGregor J M, Newell M, Ross J, et al. Cutaneous malignant melanoma and human immunodeficiency virus (HIV) infection: A report of three cases. Br J Dermatol 1992; 126: 516–519
   PubMed Web of Science ®Google Scholar
• Bernstein L, Levin D, Menck H, Ross R K. AIDS-related secular trends in cancer in Los Angeles County men: A comparison by marital status. Cancer Res 1989; 49: 466–470
   PubMed Web of Science ®Google Scholar
• Reynolds P, Saunders L D, Layefsky M E, Lemp G P. The spectrum of acquired immunodeficiency syndrome (AIDS)-associated malignancies in San Francisco, 1980–1987. Am J Epidemiol 1993; 137: 19–30
   PubMed Web of Science ®Google Scholar
• Goedert J J, Cote T R. Conjunctival malignant disease with AIDS in USA. Lancet 1996; 346: 257–258
   Web of Science ®Google Scholar
• Tindall B, Finlayson R, Mutimer K, et al. Malignant melanoma associated with human immunodeficiency virus infection in three homosexual men. J Am Acad Dermatol 1989; 20: 587–591
   PubMed Web of Science ®Google Scholar
• Merkle T, Braun-Falco O, Froschl M, et al. Malignant melanoma in human immunodeficiency virus type 2 infection. Arch Dermatol 1991; 127: 266–267
   PubMed Web of Science ®Google Scholar
• Spatz A, Prade M, Duvillard P, et al. Malignant melanoma and Kaposi's sarcoma: a possible additional syndrome to AIDS-related complex. AIDS 1990; 43: 264
   Google Scholar
• Van Landuyt H, Drobacheff C, Bertrand M A, Laurent R. Melanome malin atypique chez un malade VIH positif. Association fortuite? Presse Med 1993; 22: 553
   PubMedGoogle Scholar
• Smith K J, Skelton H G, Yeager J, et al. Cutaneous neoplasms in a military population of HIV-1 positive patients. J Am Acad Dermatol 1993; 29: 400–406
   PubMed Web of Science ®Google Scholar
• Krause W, Mittag H, Gieler U, et al. A case of malignant melanoma in AIDS-related complex. Arch Dermatol 1987; 123: 867–868
   PubMed Web of Science ®Google Scholar
• Moore G E, Cook D D. AIDS in association with malignant melanoma and Hodgkin's disease. J Clin Oncol 1985; 3: 1437
   PubMed Web of Science ®Google Scholar
• Rivers J K, Kopf A W, Postel A H. Malignant melanoma in a man seropositive for the human immunodeficiency virus. J Am Acad Dermatol 1989; 20: 1127–1128
   PubMed Web of Science ®Google Scholar
• Gupta S, Imam A. Malignant melanoma in a homosexual man with HTLV-III/LAV exposure. Am J Med 1987; 82: 1027–1030
   PubMed Web of Science ®Google Scholar
• Van Ginkel C J, Sang R T, Blaauwgeers J L, et al. Multiple primary malignant melanomas in an HIV-positive man. J Am Acad Dermatol 1991; 24: 284–285
   PubMed Web of Science ®Google Scholar
• Clark W H, Jr, Elder D E, Guerry D, IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 1989; 81: 1893–1904
   PubMed Web of Science ®Google Scholar
• Fauci A S, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med 1996; 124: 654–663
   PubMed Web of Science ®Google Scholar
• Smith K J, Skelton H G, Heimer W. Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol 1993; 29: 539–544
   PubMedGoogle Scholar
• Brigitte M, Dutarte H, Huard A, et al. Skin hyperpigmentation in AIDS patients: hypophyseal dysfunction?. Int Conf AIDS 1991; 7: 230, (abstract)
   Google Scholar